Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,255,996 papers from all fields of science
Search
Sign In
Create Free Account
FANCONI ANEMIA, COMPLEMENTATION GROUP D1
Known as:
FAD1
, FANCD1
Fanconi anemia caused by mutations of the BRCA2 gene.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Anemia
Anus, Imperforate
Autosomal recessive inheritance
BRCA2 Protein
Expand
Broader (1)
Fanconi Anemia
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia
G. Pouliot
,
James Degar
,
+18 authors
A. Gutierrez
PLoS ONE
2019
Corpus ID: 208019461
BRCA2 (also known as FANCD1) is a core component of the Fanconi pathway and suppresses transformation of immature T-cells in mice…
Expand
2016
2016
[Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene--Case Report].
A. Puchmajerová
,
K. Svojgr
,
+7 authors
L. Forétova
Klinicka onkologie
2016
Corpus ID: 36837178
Fanconi anemia is a rare autosomal recessive disorder, clinically and genetically heterogeneous, characterized by typical…
Expand
Highly Cited
2015
Highly Cited
2015
Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.
S. Sawyer
,
L. Tian
,
+9 authors
R. Greenberg
Cancer Discovery
2015
Corpus ID: 1067912
UNLABELLED Deficiency in BRCA-dependent DNA interstrand crosslink (ICL) repair is intimately connected to breast cancer…
Expand
2015
2015
Fanconi anemia gene variants in therapy-related myeloid neoplasms
M. Voso
,
E. Fabiani
,
+18 authors
D. Tenen
Blood Cancer Journal
2015
Corpus ID: 14766662
Therapy-related myeloid neoplasms (t-MN) include myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) occurring as a…
Expand
Highly Cited
2011
Highly Cited
2011
Roles of brca2 (fancd1) in Oocyte Nuclear Architecture, Gametogenesis, Gonad Tumors, and Genome Stability in Zebrafish
A. Rodríguez-Marí
,
Catherine A. Wilson
,
+11 authors
J. Postlethwait
PLoS Genetics
2011
Corpus ID: 12814959
Mild mutations in BRCA2 (FANCD1) cause Fanconi anemia (FA) when homozygous, while severe mutations cause common cancers including…
Expand
2011
2011
Mutations in Fanconi anemia genes and the risk of esophageal cancer
M. Akbari
,
R. Malekzadeh
,
+10 authors
S. Narod
Human Genetics
2011
Corpus ID: 206989249
The incidence of esophageal squamous cell carcinoma (ESCC) is very high in northeastern Iran. Previously, we reported a strong…
Expand
Review
2008
Review
2008
The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets
M. García
,
J. Benítez
Clinical and Translational Oncology
2008
Corpus ID: 7526817
Breast cancer is one of the most frequent cancers in the world. The majority of cases are sporadic but around 15% show some type…
Expand
2008
2008
A major switch for the Fanconi anemia DNA damage–response pathway
Weidong Wang
Nature Structural &Molecular Biology
2008
Corpus ID: 26607334
The Fanconi anemia pathway is part of the DNA-damage network including breast cancer–susceptibility proteins BRCA1 and BRCA2…
Expand
Highly Cited
2004
Highly Cited
2004
Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia.
J. Wagner
,
J. Tolar
,
+10 authors
A. Auerbach
Blood
2004
Corpus ID: 11460498
The breast cancer susceptibility gene BRCA2 has recently been identified as identical to the Fanconi anemia (FA) gene FANCD1…
Expand
Highly Cited
2004
Highly Cited
2004
The Genetics of FANCC and FANCG in Familial Pancreatic Cancer
C. Rogers
,
M. S. Heijden
,
+4 authors
M. Goggins
Cancer Biology & Therapy
2004
Corpus ID: 2561479
Patients with Fanconi anemia (FA) display a wide variety of defects including bone marrow failure and a high risk of developing…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE